Cell survival or apoptosis: Rooperol's role as anticancer agent

Oncology Research

Volumn 18, Issue 8, 2010, Pages 365-376

  Boukes, Gerhardt J ^a   Daniels, Brodie B ^a   Albrecht, Carl F ^b   Van de Venter, Maryna ^a  

^a NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

^b Cancer Association of South Africa   (South Africa)

Author keywords

Apoptosis; Cancer; Endoreduplication; Rooperol

Indexed keywords

ANTINEOPLASTIC AGENT; BETA GLUCOSIDASE; CASPASE 3; CASPASE 7; HYPOXOSIDE; P21 ACTIVATED KINASE; PHOSPHATIDYLSERINE; PROTEIN BCL 2; PROTEIN KINASE; ROOPEROL; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL SIZE; CELL STRAIN HT29; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG MECHANISM; ENDOREDUPLICATION; ENZYME ACTIVATION; HELA CELL; HUMAN; HUMAN CELL; HYPOXIS; IC 50; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN TRANSPORT;

EID: 77950579041     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504010X12644422320627     Document Type: Article

References (46)

1. Srivastava, V.; Negi, A. S.; Kumar, J. K.; Gupta, M. M.; Khanuja, S. P. S. Plant-based anticancer molecules: A chemical and biological profile of some important leads. Bioorg. Med. Chem. 13:5892-5908; 2005.
2. Elmore, S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 35:495-516; 2007.
3. Fadeel, B.; Orrenius, S. Apoptosis: A basic biological phenomenon with wide-ranging implications in human disease. J. Intern. Med. 258:479-517; 2005.
4. Cryns, V.; Yuan, J. Proteases to die for. Genes Dev. 12: 1551-1570; 1999.
5. Larkins, B. A.; Dilkes, B. P.; Dante, R. A.; Coelho, C. M.; Whoo, Y-M.; Liu, Y. Investigating the hows and whys of DNA endoreduplication. J. Exp. Bot. 53:183-192; 2001.
6. Sugimoto-Shirasu, K.; Roberts, K. "Big it up": Endoreduplication and cell-size control in plants. Curr. Opin. Plant Biol. 6:544-553; 2003.
7. Cortés, F.; Mateos, S.; Pastor, N.; Domínguez, I. Toward a comprehensive model for induced endoreduplication. Life Sci. 76:121-135; 2004.
8. van Wyk, B-E.; van Oudtshoorn, B.; Gericke, N. Medicinal plants of South Africa. Pretoria: Briza Publications; 1997.
9. Singh, Y. Hypoxis (Hypoxidaceae) in southern Africa: Taxonomic notes. S. Afr. J. Bot. 73:360-365; 2007.
10. Dold, A. P.; Cocks, M. L. The trade in medicinal plants in the Eastern Cape Province, South Africa. S. Afr. J. Sci. 98:589-597; 2002.
11. Albrecht, C. F.; Theron, E. J.; Kruger, P. B. Morphological characterization of the cell-growth inhibitory activity of rooperol and pharmacokinetic aspects of hypoxoside as an oral prodrug for cancer therapy. S. Afr. Med. J. 85: 853-860; 1995.
12. Nair, V. D. P.; Dairam, V.; Agbonon, A.; Arnason, J. T.; Foster, B. C.; Kanfer, I. Investigation of antioxidant activity of African potato (Hypoxis hemerocallidea). J. Agric. Food Chem. 55:1707-1711; 2007.
13. Laporta, O.; Pérez-Fons, L.; Mallavia, R.; Caturla, N.; Micol, V. Isolation, characterization and antioxidant capacity assessment of the bioactive compounds derived from Hypoxis rooperi corm extract (African potato). Food Chem. 101:1425-1437; 2007.
14. van der Merwe, M. J.; Jenkins, K.; Theron, E.; van der Walt, B. J. Interaction of the di-catehols rooperol and nor-dihydroguaiaretic acid with oxidative systems in the human blood. Biochem. Pharmacol. 45:303-311; 1993.
15. Guzdek, A.; Nizankowska, E.; Allison, A. C.; Kruger, P. B.; Koj, A. Cytokine production in human and rat mac-rophages and dicatechol rooperol and esters. Biochem. Pharmacol. 52:991-996; 1996.
16. Guzdek, A.; Turyna, B.; Allison, A. C.; Stadek, K.; Koj, A. Rooperol, an inhibitor of cytokine synthesis, decreases the respiratory burst in human and rat leukocytes and mac-rophages. Mediators Inflamm. 6:53-57; 1997.
17. Ojewole, J. A. O. Antinociceptive, anti-inflammatory and antidiabetic properties of Hypoxis hemerocallidea Fisch. & C.A. Mey. (Hypoxidaceae) corm ('African potato') aqueous extract in mice and rats. J. Ethnopharmacol. 103: 126-134; 2006.
18. Marini-Bettolo, G. B.; Patamia, M.; Nicoletti, M.; Galeffi, C.; Messana, I. Hypoxoside, a new glycoside of uncommon structure from Hypoxis obtuse Busch. Tetrahedron 38:1683-1687; 1982.
19. Drewes, S. E.; Hall, A. J.; Learmonth, R. A.; Upfold, U. J. Isolation of hypoxoside from Hypoxis rooperi and synthesis of (E)-1,5-bis(3'4'- dimethoxyphenyl)pent-4-en-1-yne. Phytochemistry 23:1313-1316; 1984.
20. Drewes, S. E.; Scogings, U. J.; Wenteller, G. L. Structure determination of a phenolic pent-1-en-4-yne derivative from Hypoxis rooperi. Phytochemistry 28:153-156; 1989.
21. Nicoletti, M.; Galeffi, C.; Messana, I.; Marini-Bettolo, G. B. Hypoxidaceae. Medicinal uses and the norlignan constituents. J. Ethnopharmacol. 36:95-101; 1992.
22. Albrecht, C. F.; Kruger, P. B.; Smit, B. J.; Freestone, M.; Gouws, L.; Miller, R.; van Jaarsveld, P. P. The pharmaco-kinetic behaviour of hypoxoside taken orally by patients with lung cancer in a phase I trial. S. Afr. Med. J. 9:861-865; 1995.
23. Smit, B. J.; Albrecht, C. F.; Liebenberg, R. W.; Kruger, P. B.; Freestone, M.; Gouws, L.; Theron, E.; Bouic, P. J. D.; Etsebeth, S.; van Jaarsveld, P. P. A phase I trial of hypoxoside as an oral prodrug for cancer therapy- absence of toxicity. S. Afr. Med. J. 9:865-870; 1995.
24. Holst-Hansen, C.; Brünnner, N. MTT-cell proliferation assay. In: Celis, J. E., ed. Cell biology: A laboratory handbook, 2nd ed. San Diego, CA: Academic Press; 1998: 16-18.
25. Kruger, P. B.; Albrecht, C. F.; Liebenberg, R. W.; van Jaarsveld, P. P. Studies on hypoxoside and rooperol analogues from Hypoxis rooperi and Hypoxis latifolia and their biotransformation in man by using high-performance liquid chromatography with in-line sorption enrichment and diode-array detection. J. Chromatogr. B 662:71-78; 1994.
26. van Engeland, M.; Nieland, L. J. W.; Ramaekers, F. C. S.; Schutte, B.; Reutelingsperger, C. P. M. Annexin V-affin-ity assay: A review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31:1-9; 1998.
27. Theron, E. J.; Albrecht, C. F.; Kruger, P. B.; Jenkins, K.; van der Merwe, M. J. ß-glucosidase activity in fetal bovine serum renders the plant glucoside, hypoxoside, cyto-toxic toward B16-F10-BL-6 mouse melanoma cells. In Vitro Cell. Div. Biol. 30A:115-119; 1994.
28. Sutou, S.; Tokuyama, F. Induction of endoreduplication in cultured mammalian cells by some chemical mutagens. Cancer Res. 34:2615-2623; 1974.
29. Coqueret, O. New roles for p21 and p27 cell-cycle inhibitors: A function for each cell compartment? Trends Cell Biol. 13:65-70; 2003.
30. Kastan, M. B.; Bartek, J. Cell-cycle checkpoints and cancer. Nature 432:316-323; 2004.
31. Nojima, H. G1 and S-phase checkpoints, chromosome instability, and cancer. Methods Mol. Biol. 280:3-49; 2004.
32. Aubry, J-P.; Blaecke, A.; Lecoanet-Henchoz, S.; Jeannin, P.; Herbault, N.; Caron, G.; Moine, V.; Bonnefoy, J-Y. Annexin V is used for measuring apoptosis in the early apoptosis events of cellular cytotoxicity. Cytometry 37: 197-204; 1999.
33. Vermes, I.; Haanen, C.; Steffens-Nakken, H.; Reutelingsperger, C. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apo-ptotic cells using fluorescein labeled Annexin-V. J. Immunol. Methods 184:39-51; 1995.
34. Jänicke, R. U.; Sprengart, M. L.; Wati, M. R.; Porter, A. G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 279:9357-9360; 1998.
35. Collins, J. A.; Schandl, C. A.; Young, K. K.; Veseley, J.; Willingham, M. C. Major DNA fragmentation is a late event in apoptosis. J. Histochem. Cytochem. 45:923-934; 1997.
36. Wolf, B. B.; Schuler, M.; Echeverri, F.; Green, D. R. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated Dnase inactivation. J. Biol. Chem. 274: 30651-30656; 1999.
37. Semenov, D. V.; Aronov, P. A.; Kuligina, E. V.; Pota-penko, M. O.; Richter, V. A. Oligonucleosome DNA fragmentation of caspase-3 deficient MCF-7 cells in palmi-tate-induced apoptosis. Nucleosides Nucleotides Nucleic Acids 23:831-836; 2004.
38. McGee, M. M.; Hyland, E.; Campiani, G.; Ramunno, A.; Nacci, V.; Zisterer, D. M. Caspase-3 is not essential for DNA fragmentation in MCF-7 cells during apoptosis induced by the pyrrolo-1,5-benzoxazepine, PBOX-6. FEBS Lett. 515:66-70; 2002.
39. Kagawa, S.; Gu, J.; Honda, T.; McDonnell, T. J.; Swisher, S. G.; Roth, J. A.; Fang, B. Deficiency of caspase-3 in MCF7 cells blocks Bax-mediated nuclear fragmentation but not cell death. Clin. Cancer Res. 7:1474-1480; 2001.
40. Kennedy, S. G.; Wagner, A. J.; Conzen, S. D.; Jordán, J.; Bellacosa, A.; Tsichlis, P. N.; Hay, N. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11:701-713; 1997.
41. Brunet, A.; Bonni, A.; Zigmond, M. J.; Lin, M. Z.; Juo, P.; Hu, L. S.; Anderson, M. J.; Arden, K. C.; Blenis, J.; Greenberg, M. E. Akt promotes cell survival by phosphor-ylating and inhibiting a Forkhead transcription factor. Cell 96:857-868; 1999.
42. Franke, T. F.; Kaplan, D. R.; Cantley, L. C. PI3K: downstream AKTion blocks apoptosis. Cell 88:435-437; 1997.
43. Murphy, K. M.; Ranganathan, V.; Farnsworth, M. L.; Kavallaris, M.; Lock, R. B. Bcl-2 inhibits Bax transloca-tion from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Diff. 7:102-111; 2002.
44. Moon, D-O.; Kim, M-O.; Choi, Y. H.; Kim, N. D.; Chang, J-H.; Kim, G-Y. Bcl-2 overexpression attenuates SP600125-induced apoptosis in human leukemia U937 cells. Cancer Lett. 264:316-325; 2008.
45. Cortés, F.; Pastor, N. Induction of endoreduplication by topoisomerase II catalytic inhibitors. Mutagenesis 18: 105-112; 2003.
46. Neukam, K.; Pastor, N.; Cortés, F. Tea flavanols inhibit cell growth and DNA topoisomerase II activity and induce endoreduplication in cultured Chinese hamster cells. Mutation Res. 654:8-12; 2008.